Thanks for visiting us! Call us at 512-329-8667 with any questions or to place orders over the phone.

Moderna COVID-19 Vaccine

Moderna COVID-19 Vaccine: 

A second dose of the Moderna Bivalent Booster is now available by walk-in on Thursdays for those eligible. 

  • CDC’s new recommendations allow an additional updated (bivalent) vaccine dose for adults ages 65 years and older and additional doses for people who are immunocompromised (see below for details). 
  • Individuals ages 6 years and older who have already received an updated mRNA vaccine do not need to take any action unless they are 65 years or older or immunocompromised.
  • Individuals over 65 who have received a single dose of a bivalent vaccine may receive on additional dose at least four months following their initial bivalent dose
  • Immunocompromised individuals who have received a bivalent vaccine may receive an additional dose at least 2 months following their initial bivalent dose

You MUST bring your Vaccine Card.

We will need the following information:

Authorized by U.S. FDA For Emergency Use. 

You may bring in your completed consent forms or fill it out when you arrive. 

Moderna Fact Sheet: 



CDC What to Expect After Getting a Vaccine- PDF

Examples of medical conditions or treatments that may result in moderate to severe immunocompromise include but are not limited to:

  • Active treatment for solid tumor and hematologic malignancies
  • Hematologic malignancies associated with poor responses to COVID-19 vaccines regardless of current treatment status (e.g., chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple myeloma, acute leukemia)
  • Receipt of solid-organ transplant or an islet transplant and taking immunosuppressive therapy
  • Receipt of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppressive therapy)
  • Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease, severe combined immunodeficiency, DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3, history of an AIDS-defining illness without immune reconstitution, or clinical manifestations of symptomatic HIV)
  • Active treatment with high-dose corticosteroids (i.e., 20 or more mg of prednisone or equivalent per day when administered for 2 or more weeks), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor necrosis factor (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory

If you have further questions, please call and ask for a vaccine coordinator.